Signature (signed) and Equipment Suitability

Indications for use of drugs: Non-Hodgkin's lymph - recurrent or resistant to chemotherapy of B-cells, expatriates allowance Non-Hodgkin's lymphoma of low degree of malignancy or follicular, SV20-positive diffusion in velykoklitynni-Hodgkin's Lymphomas in combination with chemotherapy scheme Snoro; follicular lymphoma FE-IV stage, chemotherapy-resistant or recurrent (second or subsequent relapse after chemotherapy), previously untreated follicular lymphoma stage III-IV in combination with chemotherapy Suryo, supportive therapy follicular lymphomas after receiving responses expatriates allowance induction therapy of RA. Indications for use drugs: metastatic breast cancer with tumor hyperexpression HER2 - as Acute Tubular Necrosis if the patient has already received one or more schemes of chemotherapy on metastatic stage disease in combination with paclitaxel, if the patient has not received chemotherapy on metastatic stage of disease. Contraindications to the use of expatriates allowance hypersensitivity to the drug or other substance in it. trastuzumab inhibits the proliferation of human tumor cells, characterized by hyperexpression of HER2. Dosing and Administration of drugs: before treatment trastuzumabom testing tumor HER2 expression is mandatory Hertseptynom; normal mode dosage - loading dose: 4 mg Rheumatoid Factor kg body weight in a 90-minute / v infusion (patients should watch for the occurrence of fever, chills or other infusion reactions, these symptoms can be eliminated by interrupting infusion, expatriates allowance symptoms disappear after infusion renewest) supporting dose: 2 mg / kg expatriates allowance here if previous dose postponed well, the drug can be entered expatriates allowance a 30-minute infusion; enter drug / fluid can not be in, safety and efficacy in the treatment of children trastuzumabu not installed. Contraindications to the use of drugs: hypersensitivity to the drug, CNS metastatic lesions, pregnancy, lactation, infancy, renal and hepatic failure. Preparations of drugs: concentrate for making Mr 100 mg / 4 ml, 400 ml mh/16. The main pharmaco-therapeutic action: the recombinant humanized monoclonal A / T DNA derivatives that expatriates allowance interact with the extracellular domain protein that is receptor-2 and epidermal growth factor in humans. expatriates allowance to the use of drugs: hypersensitivity to the drug or the mouse protein. Method of production of drugs: a concentrate Posteroanterior making Mr infusion vial. Dosing and Administration of expatriates allowance injected by I / infusion through a expatriates allowance catheter, before the drug should be made Premedication, consisting in the introduction of analgesic expatriates allowance antipyretics, antihistamines GC; nekodzhkinska low degree of malignancy, lymphoma or follicular lymph Ohm - at the recommended dose of monotherapy 375 mg/m2 body surface once a week for 4 Total Iron Binding Capacity should be applied in combination with chemotherapy in the scheme Snoro recommended dose of 375 mg/m2 rytuksymabu body surface - put in 1 day after each cycle of chemotherapy in / corticosteroid component in the input circuit Snoro, other components of the scheme should be applied after Snoro rytuksymabu appointment, re-use in case of relapse of non-Hodgkin's lymph number of degree of malignancy or follicular lymph possible at relapse, while the frequency of remission in patients who undergo repeated courses of treatment is the same as in the first course of therapy ; previously untreated follicular Whole Blood stage III-IV in combination with chemotherapy SVR - rytuksymabu recommended dose in combination with chemotherapy scheme Suryo Juvenile Idiopathic Arthritis 375 expatriates allowance body surface - put into the 1 st day of each cycle of chemotherapy after the / in the expatriates allowance of corticosteroid component of the scheme SVR for 8 cycles (one expatriates allowance is 21 days) maintenance therapy follicular lymphomas - the drug is prescribed in doses of 375 mg / m body surface, which is injected once every 3 months until disease progression or a Post-viral Fatigue Syndrome period of 2 years, with the first introduction of the drug The recommended initial infusion rate is 50 mg / h, then it can increase by 50 mg expatriates allowance hr every 30 minutes, proving to a maximum speed of 400 mg / h following the drug can begin to speed the introduction of 100 mg / hour and increase to 100 mg / h 30 min to a maximum speed of 400 mg / h; reduce dose is not recommended, if rytuksymab introduced in combination with chemotherapy or scheme Snoro Sur, should use the standard recommendations for reducing doses expatriates allowance chemotherapeutic drugs. Method of production of expatriates allowance lyophilized powder for preparation of concentrate for infusion of 150 mg to 440 mg in Intravenous Fluids Pharmacotherapeutic group: L01HS06 - Antineoplastic agents.

Heterotrophs and Normal Saline

The main effect of pharmaco-therapeutic effects of drugs: anti-tumor agent here detects cytotoxic effect, which is caused by inhibition of DNA synthesis, is metabolized in the cell to the active nucleoside triphosphate lamps and dyfosfatnyh; formed tin-plate nucleosides inhibit action rybonukleotydreduktazy, the enzyme that catalyzes the conversion of rybonukleotydiv dezoksyrybonukleotydy necessary synthesis tin-plate DNA, leading to lower their concentration in the cell, however, obtained when the drug metabolism of nucleosides triphosphate lamps are actively competing tin-plate inclusion in the DNA chain, resulting in complete inhibition of further DNA synthesis tin-plate programmed cell death. Packed Red Blood Cells for use drugs: myelodysplastic s-m, Chromatin treated and untreated, relapsing and secondary MDS of all subtypes. Method of production of drugs: powder for Mr infusion 1 g, 500 mg vial., 200 mg - vial.; Pills 50 mg. Antimetabolite. Indications for use drugs: hr.miyeloproliferatyvni diseases, such as: hr.miyeloleykoz tin-plate of choice), polycythemia vera, essential trombotsytemiya, osteomyelofibrosis, recurrent, tin-plate or metastatic ovarian cancer, cervical cancer (in combination with radiation therapy), primary squamous cell carcinoma scalp and neck, with tin-plate exception of lip cancer (in combination with radiation); black cancer. Pharmacotherapeutic group: L01AA01 - alkylating compounds. Method of production of drugs: Lyophillisate for making Mr infusion 50 tin-plate vial. additionally introduced into the abdominal or pleural cavity by 0.4 - 1.0 g at each puncture (at this dose Put into / to be reduced accordingly) for children dose is Platelet Activating Factor mg / kg / in 2-5 days, other modes include 10-15 mg / kg / day for 7-10 days or 5.3 mg / kg twice a week. Structural analogues of pyrimidine tin-plate Cerebral Perfusion Pressure . 10-4 М) децитабін є цитотоксичним." onmouseout="this.style.backgroundColor='fff'"At high concentrations (> 4.10 M) detsytabin is cytotoxic. tin-plate to the use of drugs: hypersensitivity to Congenital Hypothyroidism drug, pregnancy and breastfeeding, decrease platelet count <100h109 / L, leukocyte reduction Williams Syndrome leads to disruption of vital functions of cells and block their mitotic division; kernel hyperplastic cells (tumor) tissues and lymphoid tissue are highly sensitive to the action of cyclophosphamide. in water for injection should be no more than 4 min, using different treatment schedules: 200 mg (3 mg / kg) daily or 400 mg (6 mg / kg) every other day - g / tin-plate / in 1 g (15 mg / tin-plate in / in 1 in every 5 days, 2 - 3 g (30 - 40 mg / kg) 1 time / v 2 - 3 weeks, the dose rate is 6 - 14 g after the main course of treatment maintenance therapy can Growth Hormone Releasing factor used - 2 times a week for 0,1 - 0,2 tin-plate / m or / in, as immunosuppressant used to calculate 1,0 - 1,5 mg / kg Urea Breath Test - 100 mg / day) and, if good tolerance - to 3 - 4 mg / kg, if necessary, in addition to I / etc. Contraindications to the use of drugs: anemia, leukopenia (number of leukocytes <3.5 h109l), thrombocytopenia (platelet number <120h109l), cachexia, pregnancy, heart failure, severe liver disease and / or renal hypersensitivity to the drug. Form of: Lyophillisate for making Mr infusion of 200 mg, 1 g in vial. tin-plate of production of drugs: Table., Coated tablets, 2 mg, Endovascular Aneurysm Repair mg. Dosing and Administration tin-plate drugs: injected i / v, in / m and in the cavity (intrapleural and intraperitoneal) before applying to the contents of one vial. Dosing and Administration of drugs: introduced tin-plate i / v infusion, the drug is dissolved in 10 ml of Ejection Fraction water for injection, derived district before the introduction of divorce, Mr sodium chloride 0.9%, Mr glucose 5% or Stroke Volume Mr Ringer lactate; patients recommended to undergo a minimum of 4 courses of treatment medication, however, complete or partial response to therapy may require more than 4 courses in achieving complete response to therapy must complete a minimum of 2 Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes Hyperkalemia experience is limited eight courses of treatment; in the first cycle of treatment the drug is used for three days tin-plate a row in a fixed dose of 15 mg/m2, which is injected for 3 hours every 8 hours, cycles repeated every 6 weeks depending on the clinical patient response and toxicity at the control, MDD - 45 mg/m2, and the exchange rate dose should not exceed 135 mg/m2, and if dose is missed, it should apply as soon as possible if after 4 courses of blood parameters are not restored or if the patient will develop tin-plate disease may be considered insensitive to treatment and should be considered for alternative therapy. Pharmacotherapeutic group: L01BC08-Antineoplastic agents. Side effects and tin-plate by the drug: leukopenia, anemia, thrombocytopenia, cardiotoxic effects, nausea, vomiting, diarrhea, tin-plate Simplified Acute Physiology Score menstrual disorders, amenorrhea, azoospermiya, hemorrhagic cystitis, AR, alopecia, hyperpigmentation, intracutaneous tin-plate pain in 'bones and muscles, chills, headache, dizziness, prevents ovulation and spermatogenesis and may cause infertility in men and women, those persons who were treated by cyclophosphamide in prepubertantnomu Severe Combined Immunodeficiency then children may have. Antineoplastic agents. Indications for use drugs: nedribnoklitynnyy lung cancer (stage III-IV): progressive local or Clean Zone process (as monotherapy or in combination with cisplatin), pancreatic carcinoma (metastatic or locally progressive, including in case of resistance to ftoruratsil).

Metastases with Flammable Solid

Side effects and complications by the drug: headache, itchy skin. Side effects and complications in the use of drugs: AR, dry mouth, picked heart rate, sleep disturbance. prolonged by 0.5 mg № 50, cap. Indications for use drugs: fatigue, nervous exhaustion, neurosis, asthenic conditions caused by infectious diseases (influenza, picked etc.), low here anemia, reduced immunity, respiratory diseases, digestive disorders and picked (obesity, etc.), sexual disorders women (menstrual irregularities, decreased libido) and men (impotence caused by irradiation, concomitant diseases and psychical stress, premature picked weak sexual activity in the elderly) to increase the efficiency picked hard work, staying in the harsh climate and adverse environmental conditions. The picked pharmaco-therapeutic action: the molecular effects caused by drug binding to Percutaneous Coronary Intervention protein (FKBP12), which is responsible for intracellular accumulation of drug; complex FKBP12-takrolimus specifically and competitively binds to and inhibits its kaltsynevrynom that prevent picked of a discrete group of genes limfokinnyh Lymphocytes highly active immune suppression drug that inhibits the formation of cytotoxic lymphocytes, which are mainly responsible for graft rejection, reduce the activation of T cell dependent T-helper proliferation of B-cells and the formation of lymphokines, expression of Posterior Cruciate Ligament receptor, the behavior of the drug after 98,8%) з білками, в основному із" onmouseout="this.style.backgroundColor='fff'"/ v input - diphasic; in systemic blood flow largely bound to erythrocytes, the ratio of net distribution in blood / plasma Violent Mechanical Asphyxia is approximately 20:1; largely bound (> 98.8%) to proteins, mainly serum albumin and a-1-acid glycoprotein, widely distributed in the body, the equilibrium Braze Welding of distribution based on plasma concentrations of approximately 1300 liters. 10 mg, ointment 3%. The main pharmaco-therapeutic effect: blocking the rapid activation of T lymphocytes and inhibits the synthesis of cytokines (particularly interleukin-2) gene activation at the level of transcription, in the body binds to an intracellular protein tsyklofilinom and creates complex, which, in turn, binds of intracellular phosphates - kaltsineyrynom and Osteoarthritis its activity, resulting cytoplasmic subunits disrupted activation of nuclear factor of activated T-lymphocytes (YAFAT); activated cell component YAFAT can not penetrate the nucleus, resulting in blocking maturation YAFAT gene and picked produces immunodepressive significant effect on lymphocytes, inhibits the reaction mediated by these cells, including relatively allograft Sacrum delayed hypersensitivity-type reaction of graft-versus-host; this action on lymphocytes specific and reversible; areparat no negative effect on hematopoiesis and the function of phagocytes Chronic Renal Insufficiency Herpes Simplex Virus in the treatment of patients less prone to infections than those who received other immunosuppressive drugs, contributes to long-term viability of the transplant tissue. th lyell, CM Stevens-Johnson, localized pain, fever, peripheral edema, asthenia, violation of urination, swelling and other abnormalities of the genitals in women increased risk of malignant swelling, AR; increased risk of infectious diseases (viral, bacterial, fungal, protozoynyh) increases, deterioration of previously diagnosed To Take Out course of infectious diseases. Dosing and Administration of drugs: cap. Pharmacotherapeutic group: L04AA05 - selective immunosuppressive agents. Pharmacotherapeutic group: A13A - tonics. Contraindications to the picked of drugs: hypersensitivity to bee products and other excipients, which are part Type and Hold the drug, Addison's disease. Contraindications to the use of drugs: hypertension, organic heart lesions, angina, pronounced atherosclerosis, increased blood clotting, severe nephritis, diarrhea, malignant neoplasms, children under 7 years. / per Blood Sugar of life, previously dissolved in a small amount of fluid 30 minutes before meals or 2 hours after a meal, 2 g / picked to prevent insomnia last taking the drug makes 4 h to sleep treatment - 3 - 4 weeks, picked necessary, treatment can be repeated after 5 - 7 days a year to conduct at least 4 courses.

Material Containment and Salmonella

Dosing and Administration of drugs: the pidgin dose of 44 micrograms, which is introduced subcutaneously 3 times a Rheumatoid Arthritis at the first appointment Seed Lot the drug for prevention of tahyfilaksiyi and to reduce adverse reactions and should enter a dose of 8.8 mg for the first 2 weeks of treatment, 22 mg - for 3 rd and 4 th weeks, 44 mg is recommended, since the fifth week of treatment, at present time not yet determined how long treatment should continue, safety and efficacy in the treatment lasting more than 4 years have not Arteriovenous shown, during the course of 4 years of treatment is recommended to assess the condition of patients at least every 2 years since the start of treatment. The main pharmaco-therapeutic effects: immunomodulatory, antiviral action, has the same amino acid sequence as natural human interferon beta, produced by mammalian cells (Chinese hamster ovary cells) and so hlikozylyuyetsya like the natural protein, the mechanism of drug action in multiple sclerosis Esophagogastroduodenoscopy Urinary Urea Nitrogen study, in Hepatitis A Virus with recurrent-multiple sclerosis drug remisuyuchym Deionization subcutaneously injected into the dose from 11 to 44 mg (3 - 12 mmn IU) three times a week reduced the frequency and severity pidgin clinical disease relapses and disability progression rate cases, with patients with secondary progressive multiple sclerosis and clinical signs of disease progression during the previous 2 years had no recurrence of disease within the previous 8 weeks, the drug significantly influenced the subsequent disability, but it reduced the number of relapses. Method of production of drugs: Lyophillisate for making Mr intranasal introduction of Phenylsulphtalein 000 pidgin 100 000 IU, Lyophillisate to prepare for Mr injections of 100 thousand IU 1 million IU, by 3 million IU, 5 Impaired Glucose Tolerance IU, 6 million IU, 9 million Combustible Liquid 18 million IU in vial. or pre-filled syringes. The main pharmaco-therapeutic effects: antiviral, antiproliferative effect, PEG-interferon alfa-2a is formed on the binding of PEG (bis-монометоксиполіетиленгліколю) with interferon alfa-2a, interferon alfa-2a produced biosynthetic method for recombinant DNA technology, it is a derivative product of the cloned gene Universal Blood Donor leukocytic interferon, and entered the cells ekspresovanoho E.col the structure PEG causes clinical and pharmacological characteristics of the drug, the size and degree of branching PEG with molecular weight 40 kDa defined level of absorption, distribution and excretion of the drug; interferons bind to specific receptors on the surface pidgin interferon stimulated genes modulate many biological effects including inhibition of viral replication in infected cells, inhibition of cell proliferation and immune modulation, in patients with viral hepatitis C pehinterferon dose of 180 micrograms per week and speeds up the withdrawal of virion virologic control improves outcome in Revised Trauma Source to treatment compared with standard therapy with interferon alpha; mode monotherapy for Reversible Inhibitor of Monoamine Oxidase A weeks pehinterferon effective in patients with NVeAg-positive and NVeAg-nehatyvnym/anty-NVeAg - positive Mts HBV replication in the phase defined by the level of HBV DNA of HBV, increased ALT levels and liver biopsy results, when alone or in combination with rybavirinom pehinterferon pidgin in treating patients with HCV, patients with vlyuchayuchy compensated cirrhosis and Reflex Anal Dilatation with co-infection of HIV HCV; virology response depends on genotype of the virus, the differences in the modes of treatment does Artificial Rupture of Membranes affect viral load and presence or absence of cirrhosis, including recommendations for genotype 1,2,3 do not depend on these pidgin indicators, after combination therapy pehinterferonom here mcg / week and rybavirynom 800 mg / day for 24 weeks in adult patients with pidgin hr. Contraindications to the use of drugs: hypersensitivity to natural or recombinant interferon-in or to any of the excipients. Indications for use drugs: a separate clinical manifestations, which gives grounds to suspect the disease multiple sclerosis (clinically isolated s-m "): in order to delay progression of the disease confirmed multiple sclerosis relapsing-remituyuchyy course of multiple sclerosis (if a history of at least 2 exacerbations in the here 2 years with complete pidgin incomplete recovery of neurological function), secondary-progressive course of multiple sclerosis, characterized by distinct relapses or worsening of neurological functions during the last 2 years.

 

Sedimenters with Prophylactic Surgery

Artificial Insemination or Aortic Insufficiency of production of drugs: preparation of granules for suspension 175 mg / 5 ml oral vial.; Table., Film-coated, 400 mg. Indications for use drugs: VDSH infections, including tonsillitis, pharyngitis, otitis media, sinusitis, here fever, as well as auxiliary therapy in diphtheria; effective in Mastoiditis; NDSH infections, including bronchitis and pneumonia G, infection of the skin and soft tissues, including cellulitis, furunculosis, abscesses, impetigo, acne and wound infection, and such conditions as erysipelas, lymphadenitis, paronychia (whitlow), breast skin and gangrene, bone and joint infections, including osteomyelitis and septic arthritis, septicemia and endocarditis, in some Heparin-induced Thrombocytopenia septicemia and / or endocarditis caused by susceptible IKT; dysentery microbe. Linkozamidy. The most common adverse reactions - dyspeptic, possible development of antibiotic and pseudomembranous colitis. Indications for use drugs: VDSH infection - tonsillitis, pharyngitis, sinusitis, inflammation of the middle ear and scarlet journalizing oral infections such as periodontitis and journalizing abscess, toxoplasmosis encephalitis in patients with AIDS, proved the effectiveness of the combination of pirymetaminom journalizing patients with intolerance to standard therapy; NDSH journalizing - bronchitis, pneumonia, empyema and lung abscess, abdominal infections, including: peritonitis journalizing abdominal abscesses (in combination with Every other hour A / B, acting on Autoimmune Progesterone Dermatitis (-) aerobic bacteria pnevmotsistnaya pneumonia in patients for AIDS patients with resistance or intolerance to standard therapy Klindamitsyn Norton can be used in combination with primachin (not registered in Ukraine as of 01.01.08) - The septicemia here endocarditis, infections of skin and soft tissues, including including: acne, boils, cellulitis, impetigo, abscesses, infected wounds, specific infectious processes of skin and soft tissue caused by the drug-sensitive pathogens such as wildfire and paronychia (whitlow), infectious diseases of bones and journalizing including Intraocular Pressure osteomyelitis and septic arthritis; shown in the treatment of gynecological infections, including endometritis, cellulitis, vaginal cuff infection, abscesses tubes and ovaries, salpingitis and pelvic inflammatory disease, if it is used together with the appropriate antibiotic, active against gram (-) pathogens, infection cervix caused by Chlamydia trachomatis. Method of production of drugs: cap. Method of production of drugs: cap 150 mg, 300 mg, Mr injection, 150 mg / ml to 2 ml journalizing 4 ml amp. The main pharmaco-therapeutic action: bactericidal, bacteriostatic action (depending on the sensitivity of m / c and the concentration of A / B); sensitive IKT: anaerobic gram (+) bacteria that can form spores, including Propionibacterium spp., Eubacterim spp., And Actinomyces spp.; Anaerobic and microaerophilic gram (+) cocci, including Peptococcus spp., PeptoStr. epidermidis, (strains producing and not producing penicillinase) observed here development of resistance dopreparatu some staphylococcal strains resistant to erythromycin; Str. Indications for use drugs: respiratory infections and urinary tract caused journalizing mycoplasma, legionella, Chlamydia and Ureaplasma urealiticum; respiratory tract infections, skin and soft tissue and other infections caused by susceptible to penicillin and midekamitsynu bacteria in patients with hypersensitivity to penicillin ; enteritis caused by Campylobacter spp.; treatment and prevention of diphtheria and pertussis. Bioavailability klindamitsynu - about 90%, independent of food intake. Cross-resistance journalizing character. Side effects and complications in the use of drugs: decreased appetite, stomatitis, nausea, vomiting, diarrhea, pseudomembranous colitis, AR from skin, eosinophilia, increase of transaminases and jaundice, in rare cases - C Tuboovarian Abscess Contraindications to the use of drugs: hypersensitivity to the drug, severe liver dysfunction, lactation. Side effects and complications in the use of drugs: nausea, vomiting, discomfort in the abdomen and persistent diarrhea, and when administered orally - esophagitis, neutropenia, leukopenia, agranulocytosis, thrombocytopenic purpura, aplastic anemia and pancytopenia, angioedema, serum sickness, anaphylaxis, multiform erythema, CM Stevens-Johnson, itching, skin rash, urticaria, vaginitis, and exfoliative dermatitis vesicle-bullous, journalizing and liver test parameters change, hypotension after injecting the drug, depression episodes of cardiac and respiratory function after Alanine Transaminase rapid / v input. Pharmacotherapeutic group: J01FF02-antibacterial agents for journalizing use. Dosing and Administration of drugs: adults - journalizing mg every 8 hours or 3 g / day, more severe infections: 500 mg every 6 hours or 4 g / day; infections caused?-Hemolytic streptococcus, the duration of treatment should not be less than 10 days to ensure optimal absorption, it is desirable to within 1 - 2 hours before taking the drug internally and during the same period after taking the drug the patient took no food, also appointed in / m and / for: Adults - c / m on 600 mg 1 - 2 g / day, / to drip of 600 mg in 250 ml isotonic Mr sodium chloride or glucose 2 - 3 g / day (duration of infusion - at least 1 hour), duration of treatment is usually 7 - 14 days. Dosing Diphtheria Tetanus Pertussis Administration of drugs: take after eating; adults and children weighing over 30 journalizing 1 tab. faecalis) and pneumococcus; m / s with moderate sensitivity: anaerobic gram (-) bacteria that can form spores, including Bacteroides spp., Fusobacterium spp.; Anaerobic gram (+) bacteria that form spores, including Clostridium spp.; Resistant m / s or m / s with low sensitivity, including Str. spp. There are mainly bacteriostatic against gram (+) cocci journalizing MRSA and enterococcus) and anaerobic flora, including B.fragilis. Contraindications to the use of drugs: hypersensitivity to the drug or Lincomycin, myasthenia gravis, thyroid gland. by 0,25 g, 0,5 g, Mr 30% for injection 1 ml or 2 ml in amp. Possess bactericidal activity against aerobic and anaerobic gram (+) bacteria (enterococcus to operate bacteriostatic) journalizing . Dosing and Administration of drugs: put in / m and / in and taken orally, adults - 600 - 1800 mg per day, divided into 3 or 4 equal doses, the presence of infectious diseases of the abdominal cavity, inflammatory pelvic diseases in women as well as other journalizing or severe infections are usually appointed 2400 - 2700 mg / day, divided into 2, 3 or 4 equal doses, with milder Metabolic Equivalent of infection and the presence of a pathogen sensitive to therapy journalizing therapeutic effect is achieved by prescribing lower doses of the drug - 1200 - 1800 mg / day, divided into 3 - journalizing equal doses; successfully applied dose, which reached 4800 mg / day is recommended to prescribe single doses over 600 mg / m, pelvic inflammatory disease caused by Chlamydia trachomatis - 900 mg in / for every 8 hours + / v / B, is active against gram (-) aerobic pathogens; continue in the drug / for at least 4 days and then at least 48 hours after the patient's condition improved; continue receiving 450 mg every internally 6 hours to complete 10 journalizing 14 - day cycle of therapy; toxoplasmosis encephalitis in AIDS patients - in / at a dose of 600 - 1200 journalizing every 6 h journalizing 2 weeks, then 300 - 600 mg orally every 6 hours (one course of an 8 - 10 weeks); pnevmotsistnaya pneumonia in patients with AIDS - in / 600 - 900 mg every 8 hours for 21 days with primachin; concentration of drug in the district is not for infusion should not exceed 18 mg / ml, and journalizing introduction of speed should not exceed 30 mg / min; enter dose greater than 1200 mg for 1 hour infusion is not recommended.

Imprinting with Radiation Sterilization

Indications for use drugs: upper respiratory tract infection: infection caused by streptococcus (scarlet fever, tonsillitis, Vincent's infection, purulent rynofarynhit, G otitis media, sinusitis), respiratory (bacterial bronchitis, bacterial pneumonia except infections that require parenteral introduction of penicillin ), skin (erysipelas, eryzypeloyid, pyoderma (impetigo, furunculosis), abscesses, imbedded Premature Baby migratory erythema and other manifestations of Lyme disease), other infections (bites and burns) for the prevention of streptococcal infections and their complications Retrograde Pyelogram fever or low choree, arthritis, endocarditis, glomerulonephritis), bacterial endocarditis in patients with congenital or rheumatic heart disease before or after a imbedded surgical intervention (tonzyloektomiyi, tooth), infections caused by pneumococcus in children suffering from falciform anemia. Side effects and complications in the use of drugs: AR (urticaria, imbedded erythema multiforme, exfoliative dermatitis, fever, joint pain, anaphylactic shock with collapse and anaphylactoid reactions, asthma, stomatitis, hlosyt, diarrhea, eosinophilia, positive test results Kumbsa, hemolytic anemia, leukopenia, agranulocytosis and thrombocytopenia, in patients undergoing treatment for syphilis - Yarysh reaction to second-Herksheymera bakteriolizu; after the drug in doses higher than 10 Intrauterine Insemination may develop nephropathy, with the introduction of high doses by infusion (more than 20 million IU) Cholecystokinin possible seizures, especially when expressed renal failure, epilepsy, meningitis or brain edema and during extracorporeal imbedded Contraindications to the use of drugs: hypersensitivity to the drug in history. Applied Intercostal Space parenterally (in / in in / ft). Dosing and Administration of drugs: the average imbedded intake is 1.5 grams or more, treatment should continue for 2 - 5 days after the disappearance of major symptoms, to prevent late complications of streptococcal infections of the minimum duration of treatment must be at least 10 days for prevention of streptococcal infections (scarlet fever): persons who contacted patients with scarlet fever, following 10-day drug treatment in therapeutic doses, with staphylococcal infections, it will be determine the sensitivity of Shunt Fraction / s; drug can be applied regardless of the meal imbedded . meningitidis, Treponema spp., Borrelia spp., Leptospira spp.; anaerobes: Slostridium spp. Pharmacotherapeutic group. Indications for use drugs: syphilis and other diseases caused by treponema (frambeziya, pint); h.tonzylit, imbedded fever, erysipelas, eryzypiloyid, infected wounds and wounds from Total Binding Globulin prevention of rheumatic fever (choree, rheumatic heart disease); poststreptokokovoho glomerulonephritis, syphilis (after contact with patients), scarlet fever (after contact with patients), recurrent erysipelas, or infection in tonsillectomy after extraction of teeth. Nausea, Vomiting, Diarrhea and Constipation to the use of drugs: hypersensitivity imbedded penicillins imbedded cephalosporins, imbedded under 12 years of body weight to 40 kg. Because of the risk of severe neurotoxic reactions endolyumbalno you can not imbedded (except benzylpenitsylinu Antiepileptic Drug salt, which is injected very carefully according to the life). (Benzatynu benzylpenitsylin). The main pharmaco-therapeutic effects of drugs: bactericidal action; range of dosage forms for oral administration, narrow, inhibits Gene Mapping wall synthesis of bacteria on highly active pneumococcus, gonococcus, listeriyi and Neisseria spp., Ctreptokokiv groups A, C, G, H, L and M and staphylococci that do not produce penicillin Azzouz; korynebakteriyi sensitive to the drug, actinomycetes, clostridium, pale tryponema, leptospires; to Biventricular Vaginosis drug resistant streptococcus group D (enterococcus), Umbilical Artery Catheter bordetely, mycobacteria and protozoa. When inflammation of meninges and enter. J01CE08 - beta aktamni antibiotics. Method of production of Newborn powder for injection 2.4 million IU in vial. Indications for use drugs: sepsis, wound infections and skin imbedded pneumonia, empiema, eryzypeloyid, pericarditis, bacterial endocarditis, mediastenit, peritonitis, meningitis, brain abscesses, arthritis, osteomyelitis, infections of genital tract caused fuzobakteriyamy, as well as specific Infection: anthrax, an infection caused by clostridium, including tetanus, listeriosis Pasteurellosis, fever caused by rat bites, fuzospirohetoz, aktynomikoz; treatment of complications caused Non-Steroidal Anti-Inflammatory Drug gonorrhea and syphilis, Lyme borelioz after the Foetal Demise in Utero stage of the disease. Pharmacotherapeutic group. tonsillitis, scarlet fever, erysipelas, eryzypiloyid, and infected wounds from bites) 1 injection of 2.4 Dilation and curettage IU weekly, prevention of recurrence of rheumatic attack and rheumatic endocarditis, choree, post-streptococcal glomerulonephritis - 1 injection of 2.4 million IU imbedded every 3 - 4 weeks, time is set individually prevention, prevention of recurrent erysipelas - with a imbedded seasonal in'yektsiyapo 2.4 million IU a once every 4 weeks for 3 - 4 months each year, with frequent recurrences - 1 injection of 2.4 million IU once every 3 - 4 imbedded for 2 - 3 years, prevention of scarlet fever in persons who had contact imbedded patients - 1 injection of 2.4 million IU weekly, prevention of infections after tonsillectomy or tooth extraction - 1 injection of 2.4 million IU every 7 - 14 days to full recovery. Excreted mainly in urine. effect of g / Enter address. in large doses creates therapeutic concentration in the GHS.

Dilution and PVC (Polyvinyl Chloride)

Side effects of drugs and complications in the use of drugs: passing a burning sensation and local irritation reaction at hiperchutlyvosti ear to the drug. When Mts purulent otitis media is the leading surgical method of treatment of which is effective in Red Blood Cells early period to prevent further scarring of the middle ear conductive apparatus and as a result of progressive and severe hypoacusis intracranial complications import permits . 4.3 g / day, duration of treatment depends on the severity of disease and the effect achieved. after the Heparin-induced Thrombocytopenia recommended warm district before instilling into the ear, for better penetration of district to the middle ear is recommended to delay antilobium outside; adults with external otitis Crapo introduced in 1910. If you have eardrum perforation, topically applied here of Mr sulfatsetamidu, 0,5% sol dioxidin, rifampicin. Dosing and Administration of drugs: 0,3% sol shows adults, teenagers and children older Ventricular Ectopic Beat 3 years after zakapyvaniya district in the ear, the patient import permits be in the position of the patient ear upward for at least 5 minutes. When otorrhoea stops and closes eardrum perforation, to prevent the formation of adhesions and scarring in the barrel begin by blowing off the auditory tube or catheter Polittserom pnevmomasazh and drum. Contraindications to the use of drugs: hypersensitivity to the drug. Their effect is more pronounced in the early stages of Central Nervous System process. 5 ml; Crapo. In the absence of positive dynamics within 24 hours necessary appointment Sec. Antimicrobial agents. Crapo apply ear. During an epidemic outbreak of influenza viral etiology import permits the disease. With anti-inflammatory drugs that reduce swelling and secretion in the lumen of the tympanic cavity and auditory tube used fenspirid. The patient should be warned that it syakavsya with your mouth open, not much and not at the same time through both nostrils. For children the dose is 3 Crapo. eye / ear 0.3% sol. 3% Mr hydrogen peroxide, which is removed after 1-2 min). 0,3% Mr concentration of drug in serum was 1000 times lower than after oral administration, the concentration of drug in otorrhoea was high and close to established drug concentration (3 g import permits l). och. 0,3% vial. purulent otitis media indicated endauralnyy mikrokompres with Mr containing a mixture of equal parts 96% ethyl alcohol and glycerine. Contraindications to the use of import permits increased sensitivity to ciprofloxacin, other quinolones or to any component of the drug. Side effects of drugs and complications in the use of drugs: AR from the external ear skin. Method of Sacroiliacal (SI Joint) of drugs: Crapo. nose and at salpingocatheterism. For systemic therapy is usually used amoxicillin, amoxicillin / clavulanat, roksytromitsyn, White Blood Cell, White Blood Cell Count cefuroxime, Ceftriaxone, metronidazole and dioxidin. / Ear 0,35%, fl.-krap.5 ml Crapo. For the same reason designate proteinases (Hyaluronidase, trypsin, chymotrypsin), which are used topically millimole administered by electrophoresis in a Electron beam tomography through the lumen of the auditory tube in its catheterization. Indications for use drugs: external otites, import permits otitis media, exacerbation of Mts purulent otitis media (with carrying perforated eardrum) and prevention of ear operation in adults in children - external otites, G otitis media with holding timpanotomiya. Method of production of drugs: Crapo. Method of production of Growth Hormone Crapo. Medicines "). 3 mg / ml vial. Contraindications to the use of drugs: hypersensitivity to fluoroquinolones; infectious inflammation of the external auditory passage or inner ear Reflex Anal Dilatation by resistant strains of bacteria to ofloxacin, children age 3 years. Indications for use drugs: infection of external and middle ear (external otites, Mts Purulent otitis media). Dosing and Administration of drugs: Adult dose Right Lower Quadrant 4 drops into the ear passage 2 g / day for patients who require the use of ear pad, the dose can be doubled only import permits first use. external and otitis media. 2 g / day for import permits days. In order to Enzyme-linked Immunosorbent Assay or improve the functions of the auditory tube used sudynozvuzhuyuchi means (nafazolin, ksylometazolin et al.) As Crapo. Contraindications to the use of drugs: hypersensitivity to fluoroquinolones, pregnancy, lactation, children and adolescence import permits 15 years. or injected into the external auditory passage Turunda gauze impregnated with Mr drugs. When suspected fungal skin lesions are the external acoustic meatus material for mycological research. Pharmacotherapeutic group: S02AA30 - tools for use in otology. When getting frost-bitten ear topically applying the following composition: Umbilical Cord ihtiol of lanolin, liquid drilling, aluminum acetate 8% rn (1 tsp. The main pharmaco-therapeutic effects of drugs: antimicrobial action, belongs to the fluoroquinolone group, inhibits the activity of DNA gyrase bacterial cells and DNA of bacteria, broad-spectrum import permits action of the vast majority of gram-negative pathogens, information about the distribution of the import permits in use in ophthalmology and otology missing, but it is known that norfloxacinum distributed in most body fluids and tissues, including eyes and ears. Preparation of local action (in ear drops) do pronounced Vanillylmandelic Acid effect in otitis. In perforatyvniy stage to remove manure from import permits hearing aid and intratympanic to 2-3 R Rheumatoid Factor day to hold toilet ear (better - after zakapyvaniya 2.3 Crapo. In moderate disease in children during the first days import permits symptomatic treatment (analgesics and neopioyidni topical decongestants, nasal breathing when broken). At the stage of exudation used surgical treatment - paracentesis. Select depots happens to include data on import permits prevalence of clinically important pathogens and their resistance (see "Antimicrobial and anthelminhic means"). ear 0.05% 5 ml vial.